Biosimilars Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC261

A biosimilar, also known as subsequent entry biologic or follow-on biologic, is a medical product (drug) that is almost a similar or identical copy of the original product which is manufactured by some other company. These products are legitimately permitted versions of the original innovator products. They are generally manufactured when the patent of original product of the parent company expires. The key factors propelling the growth of biosimilars market include the continuous increase in pressure to reduce healthcare expenditure, growing incidences of several diseases, increasing demand for biosimilars owing to their cost-effectiveness, helpful effects in the current clinical trials, growing number of off-patented drugs, and growing biosimilars demand in various therapeutic applications including blood disorders and rheumatoid arthritis. However, factors restricting the global biosimilars demand are strict regulatory requirements in different countries, high manufacturing costs and complexities and innovative strategies applied by various biosimilar drug manufacturers to limit the entry of new players. 
The global biosimilar market is segmented based on product type, applications, technology, services and geography. The product segment of biosimilar market is further sub-segmented into recombinant non-glycosylated proteins, recombinant peptides and recombinant glycosylated proteins. Furthermore,the recombinant non-glycosylated proteins market is sub-segmented into granulocyte colony-stimulating factor insulin, human growth hormone and interferons. Also, recombinant glycosylated proteins are sub-segmented into monoclonal antibodies, follitropin and erythropoietin. On the basis of applications, the market is classified by blood disorders, growth hormone deficiency, oncology, chronic & autoimmune diseases and other applications. Oncology application segment in biosimilar market is leading due to introduction of new biosimilars whereas, chronic & autoimmune disorders is anticipated to grow in the coming years owing to the growing cases of autoimmune diseases such as psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. 
Further, technology segment is bifurcated into monoclonal antibodies technology, chromatography, electrophoresis, recombinant DNA technology, western blotting, nuclear magnetic resonance technology, bioassay and mass spectrometry. By services, the market is segmented into clinical trials and contract research & manufacturing services. Geographically, the market is bifurcated into North America, Asia-Pacific, Europe, Latin America, and Middle East, and Africa. 
Developing economies offer substantial opportunities to the manufacturers of biosimilar products. However, the global market is anticipated to face a major challenge regarding the complex infrastructure production requirements for the biosimilars and the need to obtain approval from regulatory bodies for the rigorous clinical trials. Europe is expected to dominate the biosimilars market followed by Asia-Pacific. The growth in Europe is anticipated to grow owing to the pressure for reduction in healthcare costs, introduction of new biosimilar products, biologic products patent expiry, growing incidences of chronic diseases such as diabetes and cancer; and entry of new emerging biosimilar players in the market. 
Asia-Pacific’s growth is attributed to the developing infrastructure of healthcare, rising investments in biosimilars development, huge patient population in the region and rising focus on international as well as domestic players in the Asia-Pacific region. Also, the government authorities in Asia-Pacific are focusing on promoting the use of biosimilars in order to decrease their burden towards healthcare expenses, thus providing growth opportunities to the manufacturers of biosimilars. This is backed by favorable and sound support through reimbursements related to commercialization and research; and effective regulations for biosimilar drugs. Also, the companies in developing regions are adopting alliance or collaboration strategies with key players in the developed economies in order to sustain in the market.
The key players operating in the biosimilars market include Hospira, Inc., Teva Pharmaceutical Industries Ltd., Roche Diagnostics, Sandoz International GmbH, Biocon Ltd., Amgen, Dr. Reddy's Laboratories, Mylan, Inc., Celltrion, Inc. and Merck KGAA among others.

Related Reports

Breastfeeding Accessories Market (By Product: Breastfeeding Pumps, Breast Milk Preparation & Cleaning Products, Nipple Care Products, Baby Scales, Breast Milk Storage & Feeding, Breast Shells, Breast Pads, Other Accessories; By Application: Hospital Grade, Personal Use) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global breastfeeding accessories Market is projected worth US$ 1,470.6 million by 2026 and the market is projected to showcase 10.5% CAGR during the forecast period. The breastfeeding accessories market is driven by a rise in population of working mother, the rise in birth rate and fast-paced lifestyle.

ECG Equipment and Management Systems Market (By Product Type: Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management Systems; By End Use: Hospitals & Clinics, Ambulatory Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction ECG Equipment and Management Systems is a gadget which records the heart exercises through electric signals and are enhanced on the ECG screen. ECG Equipment and Management Systems are utilized to analyze sorts of heart illnesses and arrhythmias in an individual's body in this manner help the suitable treatment. The ECG test is noninvasive and effortless method and decides irregularity designs

Macular Degeneration Treatment Market (By Disease Indication: Dry Age-related Macular Degeneration Treatment, Wet Age-related Macular Degeneration Treatment, Others; By Drug Class: Anti-vascular endothelial growth factor, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Ophthalmic Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global macular degeneration treatment Market is estimated to value US$ 11.4 Billion by 2026 and the market is projected to showcase 6.6% CAGR during the forecast period. The macular degeneration treatment market is driven by surge in healthcare spending and improved in healthcare infrastructure. Market D

Gynecological Devices Market (By Device: Surgical Devices [Endoscopy Devices, Fluid Management Systems, Endometrial Ablation Devices, Contraceptive Devices, Others], Diagnostic Imaging Systems [Ultrasound, Mammography, MRI, Others], Hand Held Instruments [Biopsy Forceps, Tenaculum, Curettes, Others], Software, Others; By End-Users: Hospitals, Clinics, Diagnostic Centres, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic i

Cart Summary